1,904
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis

, , , , , , & show all
Article: 2216322 | Received 30 Jan 2023, Accepted 20 Mar 2023, Published online: 21 Jun 2023